MedLabs InnoTalk Series
Achieve Product-Market Fit in Healthcare Innovation
Thursday, November 4th, Online Zoom Webinar
In this InnoTalk Event, we are thrilled to welcome Shannon Hall and Erin Longdo to our next InnoTalk Event. Shannon is the Co-Founder and CEO of Pow.bio, an organization dedicated to advancing the development of Industrial Synthetic Biology. Erin is an experienced diagnostics and life sciences executive leader with expertise in business, clinical diagnostics, and life science. Joining as moderator, Dr. Ella Li is the CEO of ZGC Capital and the partner of ZGC U.S. Fund, leading ZGC’s team in investment and healthcare accelerator operation.
​
The one-hour-long webinar consists of a welcome intro by Dr. Ella Li, a 40-minute fireside discussion, and a Q&A session.
​
​
ATTENDEES WILL LEARN
​​
-
What product-market fit is, and how it applies to healthcare startups
-
Ways to engage customers at each phase of the company within product development
-
The four elements of an actionable plan
-
How to overcome barriers to execute the plan and make it sustainable
-
Live Q&A Session for all attendees joining the webinar
Shannon Hall
Co-Founder and CEO of Pow.bio
Shannon Hall is Co-Founder and CEO of Pow.bio, accelerating the success of Industrial Synthetic Biology. Pow.bio is innovating a better way to test, develop and scale precision fermentation. She is committed to building success for emerging technology, serving as the Chair of the BioTrack at the UC Berkeley SkyDeck accelerator. Shannon is an active investor and deal lead with Life Science Angels.
​
Shannon Hall has over 25 years of experience building market-leading solutions at Bio-Rad Laboratories. In her last corporate role, she served as President of the Life Sciences Tools Business, growing multiple product lines aligned to improved food safety and successful drug development. She loves building teams that accomplish great work together. Shannon earned her BA in Biology from the College of St. Benedict in Minnesota.
Erin Longdo
Diagnostics and Life Sciences Executive Leader
Erin is an accomplished biotechnology executive with a diverse skill set spanning business, clinical diagnostics, and life science who effectively introduces innovative technologies and systems into regulated laboratory environments. Recently, she has been advising companies and executive teams on strategic priorities and go to market planning.
Erin serves as the Board Chair for Business for Health Solutions, a nonprofit using digital tools to strengthen healthcare access in Africa. She is the former VP/GM Clinical Immunology at Bio-Rad Laboratories. Presently, she serves as a mentor in the Global Social Benefit Incubator program through the Miller Center at Santa Clara University.
​
Erin holds a Berkeley Columbia Executive MBA, a BS in Genetics from Iowa State University and a BS in Medical Technology from the University of Iowa.
Dr. Ella Li（moderator）
Partner of ZGC US Fund, CEO of ZGC Capital
Dr. Ella Li the CEO of ZGC Capital and also the partner of ZGC U.S. Fund, leading ZGC’s team in investment and incubator operation. She’ established and managed several VC and fund of funds, including one with portfolio funds including KPCB, Menlo, Andreessen Horowitz, Accel and Foundation Capital. She is also the founder of Medlabs healthcare accelerator, providing companies with funding, mentorship and key resources to transform healthcare.
​
Dr. Li has 15+ years of experience in pharmaceutical and biotechnology sectors and has rich experiences in therapeutic investment opportunities from discovery and clinical proof-of-concept to commercialization. She also serves as board advisor, consultant and mentor in several major VC, accelerators, and startups. Dr. Ella Li earned her B.S. and M.S. degrees from Peking University School of Pharmacy, Ph.D. from the University of Texas Health Science Centers, and completed her postdoctoral fellowship from Harvard Medical School. Ella has extensive publications in prestigious journals with IMF over 10 including Nature Communication, Cell Metabolism, Journal of Clinical Investigation, PNAS, Molecular Cell, Diabetes etc.